Enovis Corp


Market Cap$3.21B

Compare Enovis

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Enovis CorpEnovis Corp-96.50%-1%1.90.1
marketMarket Avg58.91.26%30%-1
IndustrialsIndustrials Avg23.70.95%21%3.10.6

Target Price by Analysts

19.6% upsideEnovis Target Price DetailsTarget Price

Share Statistics

Market cap$3.21 Billion
Enterprise Value$3.64 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.61
Outstanding Shares54,840,388
Avg 30 Day Volume392,097


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-96.54
Price to Sales1.89
Price to Book Ratio0.94
Enterprise Value to Revenue2.13
Enterprise Value to EBIT-75.27
Enterprise Value to Net Income-110
Total Debt to Enterprise0.13
Debt to Equity0.14

Revenue Sources

No data

ESG Score

No data

About Enovis Corp

15,400 employees
CEO: Matthew Trerotola

Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...